CI
ASMB icon

Cowen Inc’s Assembly Biosciences ASMB Stock Holding History

Cowen Inc’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-797
Closed -$115K – 219
2013
Q2 		$115K Buy
+797
New +$125K 0.01% 230

Other funds holding ASMB

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen Inc's ASMB Position: Q3 2013 in Review

Cowen Inc sold out of Assembly Biosciences (ASMB) in Q3 2013, closing a stake of 797 shares — an estimated $115K sold.

Cowen Inc first reported a position in ASMB in Q2 2013 and held it in 1 quarter. The position peaked at $115K in Q2 2013. 37 funds tracked by Wall St. Rank hold ASMB as of Q3 2013.

  • Cowen Inc reported no remaining Assembly Biosciences position as of Q3 2013 after selling out during the quarter.
  • Cowen Inc sold 797 Assembly Biosciences shares in Q3 2013, an estimated $115K.
  • Cowen Inc first reported a position in Assembly Biosciences in Q2 2013 and held it in 1 quarter.
  • Cowen Inc's Assembly Biosciences position peaked at $115K in Q2 2013.
  • 37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2013.

Based on Cowen Inc's 13F filing for Q3 2013, filed 15 Nov 2013.